News

JAMA Psychiatry Study

Clinicians Identify Buprenorphine “Spiking” In JAMA Psychiatry Study Supported by Millennium Health Researchers

SAN DIEGO, Calif. – March 22, 2023 – A JAMA Psychiatry study, led by Jarratt D. Pytell, MD, MHS, Department of Medicine, University of Colorado School of Medicine, and co-authored by Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management, and Millennium Health researchers calls attention to factors associated with patients who have urine drug test (UDT) samples suggestive of buprenorphine “ADD-IN” (commonly referred to as “spiking”). Read More

Signals Report Vol. 5

Fentanyl Is Widening Grip on the Nation as Western Presence and Detection with Other Drugs Increase to Record Highs, Millennium Health Signals Report™ Shows

Fentanyl co-detection in individuals using heroin, prescription opioids, methamphetamine or cocaine reached historic levels in 2022; Drug test data also show evolution of dangerous fentanyl analogues, with geographical differences

SAN DIEGO, Calif. – February 21, 2023 – Detection of fentanyl in urine drug test (UDT) specimens remains near historic highs and fentanyl co-detection in individuals using heroin, prescription opioids, methamphetamine, or cocaine has reached new heights, according to the Millennium Health Signals Report™ released today.

Read More

CDC Collaboration

Millennium Health and CDC Collaborate on Detecting Drug Use Trends Using Testing Data

Millennium Health’s real-time data and analytics is designed to help the agency prevent fentanyl and other drug overdose deaths.

SAN DIEGO, Calif. – February 7, 2023 – Millennium Health, a leading drug testing company, announced a multi-year contract to support the Centers for Disease Control and Prevention (CDC) in their efforts to save lives and prevent fatal drug overdoses.Read More

Arizona: Increase in Fentanyl Exposure

Arizona Experiencing Increase in Illicit Fentanyl Exposure

Millennium Health Releases Emerging Threat Intelligence™ Report to Help Prevent Opioid Overdoses

SAN DIEGO, Calif. – December 8, 2022 – Millennium Health announced today that illicit fentanyl positivity in Arizona increased by 261% in patient samples from substance use disorder treatment practices tested during the first half of 2022 compared to 2019.Read More

Minnesota: Increase in Fentanyl Exposure

Minnesota Experiencing Increase in Illicit Fentanyl Exposure

Millennium Health Releases Emerging Threat Intelligence™ Report to Help Prevent Opioid Overdoses

SAN DIEGO, Calif. – October 20, 2022 – Millennium Health announced today that illicit fentanyl positivity in Minnesota increased by 400% in patient samples from substance use disorder treatment practices tested during the first half of 2022 compared to 2019.Read More

Washington: Increase in Fentanyl Use

Washington Experiencing Substantial Increase in Illicit Fentanyl Use for 2022

Millennium Health’s Emerging Threat Intelligence™ Report Finds King and Snohomish Counties Experiencing the Most Significant Increases Statewide

SAN DIEGO, Calif. – September 22, 2022 – A dramatic increase in drug overdose deaths, primarily due to illicit fentanyl, is being reported across the U.S.1 Contributing to these deaths is the proliferation of counterfeit pills often containing fentanyl that are nearly impossible to distinguish from authentic medications.2Read More

PAINWeek 2022 Poster

Millennium Health and Penn State College of Medicine Poster Presented at PAINWeek Regarding Illicit Drug Use Among People with Chronic Pain

SAN DIEGO, Calif. – September 13, 2022 – A study led by Monika Holbein, MD of Penn State College of Medicine and co-authored by Millennium Health researchers, demonstrated that urine specimens from pain management practices tested positive for heroin, illicit fentanyl, cocaine, and methamphetamine more often in patients who were not being prescribed opioids than for those patients who were prescribed opioids. Read More

Journal of Opioid Management Study

Millennium Health Publication in Journal of Opioid Management Provides Encouraging Data on Drug Use Trends in Patients Treated in Pain Management Practices Prescribed Opioids

SAN DIEGO, Calif. – September 7, 2022 – A study published in Journal of Opioid Management, led by Millennium Health researchers and co-authored by Kevin Zacharoff, MD, FACIP, FACPE, FAAP of Stony Brook University, explored the presence of illicit substances in definitive urine drug test (UDT) results in patients prescribed opioids.Read More

UnitedHealthcare Preferred Lab Network

Millennium Health Selected for the UnitedHealthcare Preferred Lab Network

SAN DIEGO, Calif. – August 31, 2022 – Millennium Health is pleased to announce that for the third year in a row, we have been chosen to be a part of the UnitedHealthcare Preferred Lab Network (PLN). Read More